Mercury Labs

{
  "main_header": {
    "sid": 287757,
    "name": "Mercury Labs",
    "stock_name": "Mercury Labs",
    "full_name": "Mercury Laboratories Ltd",
    "name_url": "stocks-analysis/mercury-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "805.15",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "805.15",
    "mcapval": "97.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538964,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE947G01011",
    "curr_date": "Feb 12",
    "curr_time": "",
    "bse_nse_vol": "1 ",
    "exc_status": "Active",
    "traded_date": "Feb 12, 2026",
    "traded_date_str": "2026 02 12",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mercury-labs-287757-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mercury Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-is-rated-sell-3824088",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MercuryLaborato_mojoScore_3824088.png",
        "date": "2026-02-06 10:10:50",
        "description": "Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "When is the next results date for Mercury Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mercury-laboratories-ltd-3823152",
        "imagepath": "",
        "date": "2026-02-05 23:17:35",
        "description": "The next results date for Mercury Laboratories Ltd is scheduled for 11 February 2026...."
      },
      {
        "title": "Mercury Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-is-rated-sell-3804580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MercuryLaborato_mojoScore_3804580.png",
        "date": "2026-01-26 10:10:30",
        "description": "Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Mercury Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-is-rated-sell-3792779",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MercuryLaborato_mojoScore_3792779.png",
        "date": "2026-01-15 10:10:27",
        "description": "Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Why is Mercury Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-mercury-laboratories-ltd-fallingrising-3792395",
        "imagepath": "",
        "date": "2026-01-15 00:46:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Mercury Laboratories Ltd has experienced a consistent decline over the past week, with its stock price dropping by 3.03%, which is significantly steeper than the Sensex’s 1.86% fall during the same period. Over the last month, the stock’s performance further deteriorated, falling 4.21% compared to the Sensex’s 2.21% decline. Year-to-date, the stock has marginally outperformed the benchmark, registering a smaller loss of 1.38% against the Sensex’s 2.16% drop. However, the longer-term picture remains less favourable, with the stock posting an 11.21% loss over the past year while the Sensex gained 9.00% in that timeframe.</p>\n<p>Despite some positive returns over three and five years, where Mercury Laboratories Ltd recorded gains of 5...."
      },
      {
        "title": "Mercury Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-is-rated-sell-3780555",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MercuryLaborato_mojoScore_3780555.png",
        "date": "2026-01-04 10:10:04",
        "description": "Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Mercury Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-is-rated-sell-3768530",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MercuryLaborato_mojoScore_3768530.png",
        "date": "2025-12-24 20:23:35",
        "description": "Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 December 2025, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mercury Laboratories: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-downgraded-to-sell-amid-technical-weakness-and-long-term-underperformance-3743119",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MercuryLaborato_mojoScore_3743119.png",
        "date": "2025-12-03 08:14:40",
        "description": "Mercury Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s evaluation metrics, providing investors with a comprehensive understanding of its current standing."
      },
      {
        "title": "How has been the historical performance of Mercury Labs?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-mercury-labs-3742230",
        "imagepath": "",
        "date": "2025-12-02 22:57:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the past seven years, Mercury Labs’ net sales have shown a generally upward trend, rising from ₹55.52 crores in March 2019 to ₹75.10 crores in March 2025. The company experienced a notable jump in sales between March 2021 and March 2022, increasing from ₹68.60 crores to ₹57.92 crores, followed by stabilisation around the ₹75 crore mark in subsequent years. Despite minor fluctuations, the revenue base has remained relatively stable in the ₹75 crore range in the last three years.</p>\n<p>Operating profit margins, excluding other income, have seen some contraction, moving from 13.98% in March 2021 to 9.35% in March 2025. This decline reflects rising costs, particularly in employee expenses which increased from ₹7.83 crores in 2019 to ₹16.84 c..."
      }
    ],
    "total": 111,
    "sid": "287757",
    "stock_news_url": "https://www.marketsmojo.com/news/mercury-laboratories-287757"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025",
      "datetime": "04-Feb-2026",
      "details": "Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Unaudited Financial Results for the quarter and nine months ended on December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Jan-2026",
      "details": "Compliance certificate under Reg 74(5) SEBI(DP) Reg 2018 for the quarter ended on December 31 2025 is attached",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Dec-2025",
      "details": "Intimation for Closure of Trading Window for the announcement unaudited Financial Results for the quarter and nine months ended on Dec 31 2025 is attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mercury Laboratories Ltd has declared <strong>35%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mercury Laboratories Ltd is Rated Sell

2026-02-06 10:10:50

Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

When is the next results date for Mercury Laboratories Ltd?

2026-02-05 23:17:35

The next results date for Mercury Laboratories Ltd is scheduled for 11 February 2026....

Read full news article

Mercury Laboratories Ltd is Rated Sell

2026-01-26 10:10:30

Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Mercury Laboratories Ltd is Rated Sell

2026-01-15 10:10:27

Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Mercury Laboratories Ltd falling/rising?

2026-01-15 00:46:30

Recent Price Movement and Market Comparison

Mercury Laboratories Ltd has experienced a consistent decline over the past week, with its stock price dropping by 3.03%, which is significantly steeper than the Sensex’s 1.86% fall during the same period. Over the last month, the stock’s performance further deteriorated, falling 4.21% compared to the Sensex’s 2.21% decline. Year-to-date, the stock has marginally outperformed the benchmark, registering a smaller loss of 1.38% against the Sensex’s 2.16% drop. However, the longer-term picture remains less favourable, with the stock posting an 11.21% loss over the past year while the Sensex gained 9.00% in that timeframe.

Despite some positive returns over three and five years, where Mercury Laboratories Ltd recorded gains of 5....

Read full news article

Mercury Laboratories Ltd is Rated Sell

2026-01-04 10:10:04

Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Mercury Laboratories Ltd is Rated Sell

2025-12-24 20:23:35

Mercury Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 December 2025, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Mercury Laboratories: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-03 08:14:40

Mercury Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s evaluation metrics, providing investors with a comprehensive understanding of its current standing.

Read full news article

How has been the historical performance of Mercury Labs?

2025-12-02 22:57:26

Revenue and Profitability Trends

Over the past seven years, Mercury Labs’ net sales have shown a generally upward trend, rising from ₹55.52 crores in March 2019 to ₹75.10 crores in March 2025. The company experienced a notable jump in sales between March 2021 and March 2022, increasing from ₹68.60 crores to ₹57.92 crores, followed by stabilisation around the ₹75 crore mark in subsequent years. Despite minor fluctuations, the revenue base has remained relatively stable in the ₹75 crore range in the last three years.

Operating profit margins, excluding other income, have seen some contraction, moving from 13.98% in March 2021 to 9.35% in March 2025. This decline reflects rising costs, particularly in employee expenses which increased from ₹7.83 crores in 2019 to ₹16.84 c...

Read full news article

View All News